Filing Details

Accession Number:
0000899243-17-015234
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-05 08:01:00
Reporting Period:
2017-06-01
Filing Date:
2017-06-05
Accepted Time:
2017-06-05 08:01:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1269021 Portola Pharmaceuticals Inc PTLA () 0331
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021944 Ltd (Private) Holdings Temasek 60B Orchard Road #06-18, Tower 2
The Atrium@Orchard
Singapore U0 238891
No No Yes No
1379348 Ltd Pte Management Fullerton 60B Orchard Road #06-18, Tower 2
The Atrium@Orchard
Singapore U0 238891
No No Yes No
1434871 Ltd Pte (Mauritius) Investments Cairnhill C/O Cim Corporate Services Ltd.,
Les Cascades, Edith Cavell St.
Port Louis O4
No No Yes No
1512375 Ltd Pte (Mauritius) Maxwell C/O Cim Corporate Services Ltd.,
Les Cascades, Edith Cavell St.
Port Louis O4
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-06-01 1,700,000 $34.40 4,133,568 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Maxwell (Mauritius) Pte Ltd ("Maxwell") owns 4,133,568 shares of the Issuer's common stock ("Shares") and V-Sciences Investments Pte Ltd ("V-Sciences") owns 750,000 Shares. Maxwell is wholly owned by Cairnhill Investments (Mauritius) Pte Ltd, which is wholly owned by Fullerton Management Pte Ltd ("FMPL"). V-Sciences is wholly owned by Temasek Life Sciences Private Limited, which is wholly owned by FMPL. FMPL is wholly owned by Temasek Holdings (Private) Limited. Accordingly, each of FMPL and Temasek Holdings (Private) Limited, through the ownership described herein, may be deemed to beneficially own the 4,883,568 Shares owned by Maxwell and V-Sciences, collectively.